UniProt ID | ARBK2_HUMAN | |
---|---|---|
UniProt AC | P35626 | |
Protein Name | Beta-adrenergic receptor kinase 2 | |
Gene Name | GRK3 {ECO:0000312|MIM:109636} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 688 | |
Subcellular Localization | ||
Protein Description | Specifically phosphorylates the agonist-occupied form of the beta-adrenergic and closely related receptors.. | |
Protein Sequence | MADLEAVLADVSYLMAMEKSKATPAARASKRIVLPEPSIRSVMQKYLAERNEITFDKIFNQKIGFLLFKDFCLNEINEAVPQVKFYEEIKEYEKLDNEEDRLCRSRQIYDAYIMKELLSCSHPFSKQAVEHVQSHLSKKQVTSTLFQPYIEEICESLRGDIFQKFMESDKFTRFCQWKNVELNIHLTMNEFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHARISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDTFSPELKSLLEGLLQRDVSKRLGCHGGGSQEVKEHSFFKGVDWQHVYLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDCDQELYKNFPLVISERWQQEVTETVYEAVNADTDKIEARKRAKNKQLGHEEDYALGKDCIMHGYMLKLGNPFLTQWQRRYFYLFPNRLEWRGEGESRQNLLTMEQILSVEETQIKDKKCILFRIKGGKQFVLQCESDPEFVQWKKELNETFKEAQRLLRRAPKFLNKPRSGTVELPKPSLCHRNSNGL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
13 | Phosphorylation | AVLADVSYLMAMEKS HHHHHHHHHHHHHHC | 10.59 | 16725308 | |
45 | Ubiquitination | SIRSVMQKYLAERNE HHHHHHHHHHHHHCC | 24.92 | - | |
57 | Ubiquitination | RNEITFDKIFNQKIG HCCCCHHHHHHHHHH | 45.03 | - | |
62 | Ubiquitination | FDKIFNQKIGFLLFK HHHHHHHHHHHHHHH | 45.99 | - | |
84 | Ubiquitination | NEAVPQVKFYEEIKE HHHCHHHHHHHHHHH | 36.66 | - | |
90 | Ubiquitination | VKFYEEIKEYEKLDN HHHHHHHHHHHHCCC | 58.48 | - | |
94 | Ubiquitination | EEIKEYEKLDNEEDR HHHHHHHHCCCHHHH | 61.31 | - | |
109 | Phosphorylation | LCRSRQIYDAYIMKE HHHHHHHHHHHHHHH | 6.03 | 22817900 | |
112 | Phosphorylation | SRQIYDAYIMKELLS HHHHHHHHHHHHHHC | 9.92 | 22817900 | |
115 | Ubiquitination | IYDAYIMKELLSCSH HHHHHHHHHHHCCCC | 35.33 | - | |
119 | Phosphorylation | YIMKELLSCSHPFSK HHHHHHHCCCCCCCH | 26.63 | 29083192 | |
121 | Phosphorylation | MKELLSCSHPFSKQA HHHHHCCCCCCCHHH | 30.71 | 24719451 | |
125 | Phosphorylation | LSCSHPFSKQAVEHV HCCCCCCCHHHHHHH | 28.45 | 29083192 | |
126 | Ubiquitination | SCSHPFSKQAVEHVQ CCCCCCCHHHHHHHH | 42.53 | - | |
138 | Ubiquitination | HVQSHLSKKQVTSTL HHHHHHCHHHHHHHH | 54.29 | - | |
139 | Ubiquitination | VQSHLSKKQVTSTLF HHHHHCHHHHHHHHH | 46.77 | - | |
164 | Ubiquitination | LRGDIFQKFMESDKF HCCCHHHHHHHCCCC | 35.61 | - | |
170 | Ubiquitination | QKFMESDKFTRFCQW HHHHHCCCCHHHHCC | 58.89 | - | |
206 | Phosphorylation | RGGFGEVYGCRKADT CCCCCCCCCCCCCCC | 13.25 | - | |
213 | Phosphorylation | YGCRKADTGKMYAMK CCCCCCCCCCEEEEH | 43.49 | 22964224 | |
215 | Ubiquitination | CRKADTGKMYAMKCL CCCCCCCCEEEEHHH | 30.72 | - | |
220 | Ubiquitination | TGKMYAMKCLDKKRI CCCEEEEHHHCHHHC | 24.39 | - | |
230 | Ubiquitination | DKKRIKMKQGETLAL CHHHCCCCCCCEEEE | 50.58 | - | |
247 | Phosphorylation | RIMLSLVSTGDCPFI HHHHHHHCCCCCCEE | 31.78 | 22817900 | |
248 | Phosphorylation | IMLSLVSTGDCPFIV HHHHHHCCCCCCEEE | 29.56 | - | |
319 | Ubiquitination | FVVYRDLKPANILLD EEEEECCCHHHEEEC | 46.50 | - | |
344 | Ubiquitination | GLACDFSKKKPHASV CCCCCCCCCCCCCCC | 65.88 | - | |
345 | Ubiquitination | LACDFSKKKPHASVG CCCCCCCCCCCCCCC | 71.04 | - | |
346 | Ubiquitination | ACDFSKKKPHASVGT CCCCCCCCCCCCCCC | 45.85 | - | |
350 | Phosphorylation | SKKKPHASVGTHGYM CCCCCCCCCCCCCCC | 20.32 | 19369195 | |
353 | Phosphorylation | KPHASVGTHGYMAPE CCCCCCCCCCCCCHH | 15.24 | 22817900 | |
356 | Phosphorylation | ASVGTHGYMAPEVLQ CCCCCCCCCCHHHHH | 5.19 | - | |
389 | Phosphorylation | FKLLRGHSPFRQHKT HHHHHCCCHHHHCCC | 28.67 | 27067055 | |
406 | Phosphorylation | KHEIDRMTLTVNVEL HHHCCEEEEEEEEEC | 21.85 | 21406692 | |
408 | Phosphorylation | EIDRMTLTVNVELPD HCCEEEEEEEEECCC | 10.81 | 21406692 | |
416 | Phosphorylation | VNVELPDTFSPELKS EEEECCCCCCHHHHH | 24.87 | 21406692 | |
418 | Phosphorylation | VELPDTFSPELKSLL EECCCCCCHHHHHHH | 21.40 | 24719451 | |
423 | Phosphorylation | TFSPELKSLLEGLLQ CCCHHHHHHHHHHHH | 51.30 | 21406692 | |
448 | Ubiquitination | GGGSQEVKEHSFFKG CCCCHHHHHCCCCCC | 49.29 | - | |
454 | Ubiquitination | VKEHSFFKGVDWQHV HHHCCCCCCCCCEEE | 56.89 | - | |
465 | Ubiquitination | WQHVYLQKYPPPLIP CEEEEECCCCCCCCC | 58.07 | - | |
487 | Phosphorylation | ADAFDIGSFDEEDTK HHCCCCCCCCHHHCC | 29.83 | 29978859 | |
493 | Phosphorylation | GSFDEEDTKGIKLLD CCCCHHHCCCEEEEE | 34.15 | 27732954 | |
494 | Ubiquitination | SFDEEDTKGIKLLDC CCCHHHCCCEEEEEC | 71.59 | - | |
497 | Ubiquitination | EEDTKGIKLLDCDQE HHHCCCEEEEECCHH | 52.22 | - | |
506 | Phosphorylation | LDCDQELYKNFPLVI EECCHHHHHHCCEEE | 11.79 | 27642862 | |
507 | Ubiquitination | DCDQELYKNFPLVIS ECCHHHHHHCCEEEE | 65.81 | - | |
514 | Phosphorylation | KNFPLVISERWQQEV HHCCEEEEHHHHHHH | 17.40 | 21406692 | |
522 | Phosphorylation | ERWQQEVTETVYEAV HHHHHHHHHHHHHHH | 25.78 | 22210691 | |
524 | Phosphorylation | WQQEVTETVYEAVNA HHHHHHHHHHHHHHC | 21.01 | 28796482 | |
526 | Phosphorylation | QEVTETVYEAVNADT HHHHHHHHHHHHCCH | 12.94 | 28796482 | |
533 | Phosphorylation | YEAVNADTDKIEARK HHHHHCCHHHHHHHH | 36.46 | 22210691 | |
545 | Ubiquitination | ARKRAKNKQLGHEED HHHHHHHHCCCCHHH | 46.31 | - | |
564 | Phosphorylation | KDCIMHGYMLKLGNP HHHHHHCHHHHCCCC | 5.65 | - | |
612 | Phosphorylation | QILSVEETQIKDKKC HHHCCCHHHCCCCEE | 23.30 | - | |
625 | Acetylation | KCILFRIKGGKQFVL EEEEEEEECCEEEEE | 58.30 | 7959355 | |
628 | Ubiquitination | LFRIKGGKQFVLQCE EEEEECCEEEEEEEC | 49.59 | - | |
628 | Acetylation | LFRIKGGKQFVLQCE EEEEECCEEEEEEEC | 49.59 | 7959367 | |
644 | Ubiquitination | DPEFVQWKKELNETF CHHHHHHHHHHHHHH | 21.19 | - | |
645 | Ubiquitination | PEFVQWKKELNETFK HHHHHHHHHHHHHHH | 65.56 | - | |
652 | Acetylation | KELNETFKEAQRLLR HHHHHHHHHHHHHHH | 60.61 | 25953088 | |
652 | Ubiquitination | KELNETFKEAQRLLR HHHHHHHHHHHHHHH | 60.61 | - | |
670 | Phosphorylation | KFLNKPRSGTVELPK HHHCCCCCCCCCCCC | 47.55 | 28634120 | |
672 | Phosphorylation | LNKPRSGTVELPKPS HCCCCCCCCCCCCCC | 16.44 | - | |
679 | Phosphorylation | TVELPKPSLCHRNSN CCCCCCCCCCCCCCC | 50.16 | 30576142 | |
685 | Phosphorylation | PSLCHRNSNGL---- CCCCCCCCCCC---- | 32.03 | 23898821 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ARBK2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ARBK2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CXCR4_HUMAN | CXCR4 | physical | 11668182 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00171 | Adenosine triphosphate |
loading...